CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2461
-0.0038 (-1.53%)
At close: Mar 2, 2026
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $320.26 million as of March 2, 2026. Its market cap has increased by 27.03% in one year.
Market Cap
320.26M
Enterprise Value
342.55M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.25
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 320.26M, an increase of 5,683.46%. That is a compound annual growth rate of 22.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 320.26M | -9.92% |
| Dec 31, 2025 | 355.55M | 164.08% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 361.16M |
| Silence Therapeutics | 256.95M |
| Vaxart | 190.78M |
| BioStem Technologies | 94.76M |
| Nuo Therapeutics | 72.43M |
| HST Global | 70.56M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 46.87M |